DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Mega JL et al.
Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51).
J Am Coll Cardiol 2013;
61: 1853-1859
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.